TS Nexgen Overview
- Year Founded
-
1995

- Status
-
Public
- Employees
-
84

- Stock Symbol
-
043220

- Investments
-
4
- Share Price
-
$0.12
- (As of Monday Closing)
TS Nexgen General Information
Description
TS Nexgen Co Ltd is engaged in the manufacture and selling of power plant facility dampers, ship desulfurization facilities (SOx Dampers), power distribution facility busways, and sales of regenerative medicine products and medical devices. The company's business and product division includes Power Generation Equipment, Busways, and Shipbuilding.
Contact Information
Website
www.tsnexgen.comCorporate Office
- 527 Eonju-ro, Gangnam-gu
- 3rd floor Yeoksam-dong, Gangnam Telepia Building
- Seoul, 66616
- South Korea
Corporate Office
- 527 Eonju-ro, Gangnam-gu
- 3rd floor Yeoksam-dong, Gangnam Telepia Building
- Seoul, 66616
- South Korea
TS Nexgen Stock Performance
As of 31-Mar-2025, TS Nexgen’s stock price is $0.12. Its current market cap is $18.5M with 159M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.12 | $0.17 | $0.11 - $0.88 | $18.5M | 159M | 5.58M | -$0.11 |
TS Nexgen Financials Summary
As of 31-Mar-2025, TS Nexgen has a trailing 12-month revenue of $15.3M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 45,837 | 63,280 | 44,834 | 77,912 |
Revenue | 15,301 | 15,751 | 20,303 | 19,737 |
EBITDA | (17,178) | (10,678) | 2,040 | (4,144) |
Net Income | (17,909) | (13,997) | 30 | (7,491) |
Total Assets | 82,300 | 87,113 | 57,499 | 59,055 |
Total Debt | 33,079 | 29,869 | 13,316 | 14,624 |
TS Nexgen Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
TS Nexgen Patents
TS Nexgen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170077722-A1 | Battery pack, cell module and cell module assembly | Inactive | 24-Mar-2014 |
TS Nexgen Signals
TS Nexgen Investments & Acquisitions (4)
TS Nexgen’s most recent deal was a Merger/Acquisition with Neurosona for . The deal was made on 07-May-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Neurosona | 07-May-2024 | Merger/Acquisition | Biotechnology | ||
Leeum DMC (Land and Buildings Located in South Korea) | 29-Mar-2024 | Corporate Asset Purchase | Other Business Products and Services | ||
SmartX (Medical Devices Bussiness) | 01-Apr-2021 | Merger/Acquisition | Diagnostic Equipment | ||
Samkwang Power System | 01-Jan-2017 | Merger/Acquisition | Industrial Supplies and Parts |
TS Nexgen Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Neurosona | Seoul, South Korea | 2017 |
TS Nexgen FAQs
-
When was TS Nexgen founded?
TS Nexgen was founded in 1995.
-
Where is TS Nexgen headquartered?
TS Nexgen is headquartered in Seoul, South Korea.
-
What is the size of TS Nexgen?
TS Nexgen has 84 total employees.
-
What industry is TS Nexgen in?
TS Nexgen’s primary industry is Alternative Energy Equipment.
-
Is TS Nexgen a private or public company?
TS Nexgen is a Public company.
-
What is TS Nexgen’s stock symbol?
The ticker symbol for TS Nexgen is 043220.
-
What is the current stock price of TS Nexgen?
As of 31-Mar-2025 the stock price of TS Nexgen is $0.12.
-
What is the current market cap of TS Nexgen?
The current market capitalization of TS Nexgen is $18.5M.
-
What is TS Nexgen’s current revenue?
The trailing twelve month revenue for TS Nexgen is $15.3M.
-
What is TS Nexgen’s annual earnings per share (EPS)?
TS Nexgen’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »